Intermittent Fetal Heart Monitoring with Moyo Doppler
Improving Fetal Heart Rate Detection in Ethiopia
Study Purpose: This study aimed to evaluate how effective intermittent fetal heart rate (FHR) monitoring with the Moyo Doppler is compared to the traditional fetoscope in Ethiopian hospitals in 2023.
Background: The Moyo FHR monitor was introduced to help quickly identify fetuses that may be lacking oxygen. However, there is limited information on its effectiveness in resource-limited settings like Ethiopia.
Methods: In this randomized trial (PACTR202305607000259), 2,518 low-risk women in labor were enrolled from September 28, 2022, to February 28, 2023. Participants were randomly assigned to either the Moyo group or the Pinard fetoscope group, with 1,259 women in each group. A P-value of less than 0.05 was considered significant.
Results: Abnormal FHR was detected in 60 women (5.1%) using the Moyo monitor, compared to 30 women (2.4%) using the Pinard fetoscope (P = .001).
Conclusion: The Moyo FHR monitor is more effective at detecting abnormal fetal heart rates than the Pinard fetoscope.
Practical Implications: Healthcare systems in low-resource settings are encouraged to adopt the Moyo device for better fetal heart rate monitoring.
Enhancing Clinical Practices
Clinical trials are essential for developing safe and effective treatments. It’s vital to integrate their findings into everyday medical practices. Our AI-driven platform, DocSym, brings together ICD-11 standards, clinical protocols, and research into one easy-to-use resource for healthcare professionals.
Streamlining Healthcare: In today’s medical environment, efficient operations are key. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient care management and expanding digital services.
Improving Outcomes: By leveraging AI, clinics can enhance workflows, improve patient outcomes, and reduce reliance on paper processes. Discover how we can support you at aidevmd.com.
